Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices 39087 

TABLE—REGISTRATION REVIEW PROPOSED INTERIM DECISIONS BEING ISSUED—Continued 

Registration review case name and number Docket ID No. Chemical review manager and contact information 

Gibberellins, Case 4110 ................................................... EPA–HQ–OPP–2012–0939 Cody Kendrick, kendrick.cody@epa.gov, (703) 347– 

0468. 

Indole-3-Butyric Acid, Case 2330 ..................................... EPA–HQ–OPP–2010–0608 Seiichi Murasaki, murasaki.seiichi@epa.gov, (703) 

347–0163. 

Indoxacarb, Case 7613 .................................................... EPA–HQ–OPP–2013–0367 Moana Appleyard, appleyard.moana@epa.gov, (703) 

308–8175. 

Methyl Eugenol, Case 6203 ............................................. EPA–HQ–OPP–2016–0173 Chris Pfeifer, pfeifer.chris@epa.gov, (703) 308–0031. 

Methyl Isopropenyl, Case 6090 ........................................ EPA–HQ–OPP–2017–0253 Alexandra Boukedes, boukedes.alexandra@epa.gov, 

(703) 347–0305. 

Naphthenate salts, Case 3099 ......................................... EPA–HQ–OPP–2010–0455 Rachel Ricciardi, ricciardi.rachel@epa.gov, (703) 347– 

0465. 

Nuranone, Case 4113 ...................................................... EPA–HQ–OPP–2012–0126 Seiichi Murasaki, murasaki.seiichi@epa.gov, (703) 

347–0163. 

Oxamyl, Case 0253 .......................................................... EPA–HQ–OPP–2010–0028 Bilin Basu, basu.bilin@epa.gov, (703) 347–0455. 

Prometryn, Case 0467 ...................................................... EPA–HQ–OPP–2013–0032 Christina Scheltema, scheltema.christina@epa.gov, 

(703) 308–2201. 

Pyriproxyfen, Case 7424 .................................................. EPA–HQ–OPP–2011–0677 Khue Nguyen, nguyen.khue@epa.gov, (703) 347–0248. 

Quillaja extract (Quillaja Saponins), Case 6512 ............... EPA–HQ–OPP–2017–0230 Maggie Rudick, rudick.maggie@epa.gov, (703) 347– 

0257. 

Quinoa Saponins (Extract of Chenopodium Quinoa 

Saponins), Case 6200.

EPA–HQ–OPP–2017–0274 Daniel Schoeff, schoeff.daniel@epa.gov, (703) 347– 

0143. 

Rhamnolipid biosurfactant, Case 6085 ............................ EPA–HQ–OPP–2017–0275 Cody Kendrick, kendrick.cody@epa.gov, (703) 347– 

0468. 

Salicylic Acid and Methyl Salicylate, Case 4080 .............. EPA–HQ–OPP–2017–0328 Maggie Rudick, rudick.maggie@epa.gov, (703) 347– 

0257. 

Trifloxystrobin, Case 7028 ................................................ EPA–HQ–OPP–2013–0074 Moana Appleyard, appleyard.moana@epa.gov, (703) 

308–8175. 

(Z)-9-tricosene (Muscalure), Case 4112 ........................... EPA–HQ–OPP–2010–0925 Alexandra Boukedes, boukedes.alexandra@epa.gov, 

(703) 347–0305. 

The registration review docket for a 

pesticide includes earlier documents 

related to the registration review case. 

For example, the review opened with a 

Preliminary Work Plan, for public 

comment. A Final Work Plan was 

placed in the docket following public 

comment on the Preliminary Work Plan. 

The documents in the dockets 

describe EPA’s rationales for conducting 

additional risk assessments for the 

registration review of the pesticides 

included in the table in Unit IV, as well 

as the Agency’s subsequent risk findings 

and consideration of possible risk 

mitigation measures. These proposed 

interim registration review decisions are 

supported by the rationales included in 

those documents. Following public 

comment, the Agency will issue interim 

or final registration review decisions for 

the pesticides listed in the table in Unit 

IV. 

The registration review final rule at 40 

CFR 155.58(a) provides for a minimum 

60-day public comment period on all 

proposed interim registration review 

decisions. This comment period is 

intended to provide an opportunity for 

public input and a mechanism for 

initiating any necessary amendments to 

the proposed interim decision. All 

comments should be submitted using 

the methods in ADDRESSES, and must be 

received by EPA on or before the closing 

date. These comments will become part 

of the docket for the pesticides included 

in the Table in Unit IV. Comments 

received after the close of the comment 

period will be marked ‘‘late.’’ EPA is not 

required to consider these late 

comments. 

The Agency will carefully consider all 

comments received by the closing date 

and may provide a ‘‘Response to 

Comments Memorandum’’ in the 

docket. The interim registration review 

decision will explain the effect that any 

comments had on the interim decision 

and provide the Agency’s response to 

significant comments. 

Background on the registration review 

program is provided at: http://

www.epa.gov/pesticide-reevaluation. 

Authority: 7 U.S.C. 136 et seq. 

Dated: July 16, 2018. 

Yu-Ting Guilaran, 

Director, Pesticide Re-Evaluation Division, 

Office of Pesticide Programs. 

[FR Doc. 2018–16988 Filed 8–7–18; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPP–2018–0517; FRL–9980–76] 

FIFRA Scientific Advisory Panel; 

Notice of Public Meeting and Request 

for Nomination of Ad Hoc Expert 

Members 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: There will be a 4-day, inperson meeting of the Federal 

Insecticide, Fungicide, and Rodenticide 

Act Scientific Advisory Panel (FIFRA 

SAP) to consider and review the 

Evaluation of a Proposed Approach to 

Refine the Inhalation Risk Assessment 

for Point of Contact Toxicity: A Case 

Study Using a New Approach 

Methodology (NAM). Preceding the inperson meeting, there will be a half-day 

virtual preparatory meeting, conducted 

via webinar using Adobe Connect, to 

consider and review the clarity and 

scope of the meeting’s draft charge 

questions. In addition, EPA is 

requesting nominations of prospective 

candidates for service as ad hoc 

members of FIFRA SAP for this meeting. 

Any interested person or organization 

may nominate qualified individuals to 

be considered as prospective candidates 


sradovich on DSK3GMQ082PROD with NOTICES
39088 Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices 

for this meeting by following the 

instructions provided in this document. 

DATES: 

Meeting: The 4-day, in-person 

meeting will be held December 4 to 

December 7, 2018, from approximately 

9 a.m. to 5 p.m. 

Nominations: Nominations of 

candidates to serve as ad hoc members 

of the FIFRA SAP for this review should 

be provided on or before September 7, 

2018. 

Special accommodations: Requests 

for special accommodations should be 

submitted on or before November 16, 

2018, to allow EPA time to process your 

request. 

Comments: Written comments should 

be submitted on or before October 19, 

2018, and EPA encourages individuals 

and groups that wish to make oral 

comments to submit the request to make 

oral comments by November 9, 2018. 

ADDRESSES: 

Meeting: The in-person meeting will 

be held at the Environmental Protection 

Agency, Conference Center, Lobby 

Level, One Potomac Yard (South Bldg.), 

2777 S. Crystal Dr., Arlington, VA 

22202. The virtual meeting will be 

webcast. Please refer to the following 

website for information on how to 

access the webcast: http://www.epa.gov/ 

sap. 

Nominations: Submit nominations of 

candidates to serve as ad hoc members 

of the FIFRA SAP Meeting to the DFO 

listed under FOR FURTHER INFORMATION

CONTACT. 

Special accommodations: For 

information on access or services for 

individuals with disabilities, and to 

request accommodation for a disability, 

please contact the Designated Federal 

Official (DFO) listed under FOR FURTHER

INFORMATION CONTACT. 

Comments. Submit requests to present 

oral comments to the DFO listed under 

FOR FURTHER INFORMATION CONTACT. 

Submit your written comments, 

identified by docket identification (ID) 

number EPA–HQ–OPP–2018–0517, by 

one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the online 

instructions for submitting comments. 

Do not electronically submit any 

information you consider to be 

Confidential Business Information (CBI) 

or other information whose disclosure is 

restricted by statute. 

• Mail: OPP Docket, Environmental 

Protection Agency Docket Center (EPA/ 

DC), (28221T), 1200 Pennsylvania Ave. 

NW, Washington, DC 20460–0001. 

• Hand Delivery: To make special 

arrangements for hand delivery or 

delivery of boxed information, please 

follow the instructions at http://

www.epa.gov/dockets/contacts.html. 

Additional information on 

commenting or visiting the docket, 

along with more information about 

dockets generally, is available at http:// 

www.epa.gov/dockets. For additional 

instructions related to this meeting, see 

Unit I.C. of the SUPPLEMENTARY

INFORMATION. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Marquea D. King, DFO, Office of 

Science Coordination and Policy 

(7201M), Environmental Protection 

Agency, 1200 Pennsylvania Ave. NW, 

Washington, DC 20460–0001; telephone 

number: 202–564–3626; email address: 

king.marquea@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general. This action may be of 

interest to persons who are or may be 

required to conduct testing of chemical 

substances under the Federal Food, 

Drug, and Cosmetic Act (FFDCA) and 

FIFRA. Since other entities may also be 

interested, the Agency has not 

attempted to describe all the specific 

entities that may be affected by this 

action. 

B. What should I consider as I prepare 

my comments for EPA? 

1. Submitting CBI. Do not submit CBI 

information to EPA through 

regulations.gov or email. If your 

comments contain any information that 

you consider to be CBI or otherwise 

protected, please contact the DFO listed 

under FOR FURTHER INFORMATION

CONTACT to obtain special instructions 

before submitting your comments. 

2. Tips for preparing your comments. 

When preparing and submitting your 

comments, see the commenting tips at 

http://www.epa.gov/dockets/ 

comments.html. 

C. How may I participate in both 

meetings? 

You may participate in both meetings 

by following the instructions in this 

unit. To ensure proper receipt of 

comments, nominations or other 

requests by EPA, it is imperative that 

you identify docket ID number EPA– 

HQ–OPP–2018–0517 in the subject line 

on the first page of your request. 

1. Written comments. Written 

comments for both the in-person and 

virtual meetings should be submitted, 

using the instructions in ADDRESSES and 

Unit I.B., on or before October 19, 2018, 

to provide FIFRA SAP the time 

necessary to consider and review the 

written comments. FIFRA SAP may not 

be able to fully consider written 

comments submitted after October 19, 

2018. 

2. Oral comments. To be included on 

the meeting agenda, the Agency 

encourages each individual or group 

wishing to make brief oral comments to 

FIFRA SAP during the in-person or 

virtual meetings to submit their request 

to the DFO listed under FOR FURTHER

INFORMATION CONTACT on or before 

November 9, 2018. To the extent that 

time permits, the Chair of the FIFRA 

SAP may permit the presentation of oral 

comments at the meeting by interested 

persons who have not previously 

requested time. Oral comments during 

the virtual meeting are limited to 

approximately 5 minutes due to the 

time constraints of this webcast. Oral 

comments during the 4-day, in-person 

meeting are limited to approximately 5 

minutes unless arrangements have been 

made prior to November 9, 2018. The 

request should identify the name of the 

individual making the presentation, the 

organization (if any) the individual will 

represent, and any requirements for 

audiovisual equipment. In addition, 

each speaker should bring 15 copies of 

his or her oral remarks and presentation 

slides (if required) for distribution to the 

FIFRA SAP at the meeting by the DFO. 

3. Seating at the meeting. Seating at 

the in-person meeting will be open and 

on a first-come basis. 

4. Request for nominations to serve as 

ad hoc expert members of FIFRA SAP 

for this meeting. As part of a broader 

process for developing a pool of 

candidates for each meeting, FIFRA SAP 

staff routinely solicits the stakeholder 

community for nominations of 

prospective candidates for service as ad 

hoc members of FIFRA SAP. Any 

interested person or organization may 

nominate qualified individuals to be 

considered as prospective candidates for 

a specific meeting. Individuals 

nominated for this meeting should have 

expertise in one or more of the 

following areas: (i) Development and 

implementation of new approach 

methodologies (NAMs); (ii) inhalation 

alternative testing; (iii) inhalation 

toxicology; (iv) inhalation exposure 

assessment; (v) inhalation/ 

computational fluid dynamic (CFD) 

modeling; and (vi) risk assessment. 

Nominees should be scientists who have 

sufficient professional qualifications, 

including training and experience, to 

provide expert comments on the 

scientific issues for this meeting. 

Nominees should be identified by name, 

occupation, position, address, email 

address, and telephone number. 

Nominations should be provided to the 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices 39089 

DFO listed under FOR FURTHER

INFORMATION CONTACT on or before 

September 7, 2018. The Agency will 

consider all nominations of prospective 

candidates for this meeting that are 

received on or before that date. 

However, final selection of ad hoc 

members for this meeting is a 

discretionary function of the Agency. 

The selection of scientists to serve on 

FIFRA SAP is based on the function of 

the Panel and the expertise needed to 

address the Agency’s charge to the 

Panel. No interested scientists shall be 

ineligible to serve by reason of their 

membership on any other advisory 

committee to a Federal department or 

agency or their employment by a 

Federal department or agency, except 

EPA. Other factors considered during 

the selection process include 

availability of the potential Panel 

member to fully participate in the 

Panel’s review, absence of any conflicts 

of interest or appearance of loss of 

impartiality, independence with respect 

to the matters under review, and lack of 

bias. Although financial conflicts of 

interest, the appearance of loss of 

impartiality, lack of independence, and 

bias may result in disqualification, the 

absence of such concerns does not 

assure that a candidate will be selected 

to serve on FIFRA SAP. Numerous 

qualified candidates are identified for 

each Panel; therefore, selection 

decisions involve carefully weighing a 

number of factors, including the 

candidates’ areas of expertise and 

professional qualifications and 

achieving an overall balance of different 

scientific perspectives on the Panel. In 

order to have the collective breadth of 

experience needed to address the 

Agency’s peer review charge for this 

meeting, the Agency anticipates 

selecting approximately 13 ad hoc 

scientists. 

FIFRA SAP members are subject to 

the provisions of 5 CFR part 2634— 

Executive Branch Financial Disclosure, 

Qualified Trusts, and Certificates of 

Divestiture, as supplemented by EPA in 

5 CFR part 6401. In anticipation of this 

requirement, prospective candidates for 

service on FIFRA SAP will be asked to 

submit confidential financial 

information which shall fully disclose, 

among other financial interests, the 

candidate’s employment, stocks, and 

bonds, and where applicable, sources of 

research support. EPA will evaluate the 

candidate’s financial disclosure form to 

assess whether there are financial 

conflicts of interest, appearance of a loss 

of impartiality, or any prior involvement 

with the development of the documents 

under consideration (including previous 

scientific peer review) before the 

candidate is considered further for 

service on FIFRA SAP. Those who are 

selected from the pool of prospective 

candidates will be asked to attend the 

public meetings and to participate in the 

discussion of key issues and 

assumptions at these meetings. In 

addition, they will be asked to review 

and to help finalize the meeting minutes 

and final report. The list of FIFRA SAP 

members participating at this meeting 

will be posted on the FIFRA SAP 

website at http://www.epa.gov/scipoly/ 

sap or may be obtained from the OPP 

Docket at http://www.regulations.gov. 

II. Background 

A. Purpose of FIFRA SAP 

The FIFRA SAP serves as one of the 

primary scientific peer review 

mechanisms of EPA’s Office of 

Chemical Safety and Pollution 

Prevention (OCSPP) and is structured to 

provide independent scientific advice, 

information and recommendations to 

the EPA Administrator on pesticides 

and pesticide-related issues as to the 

impact of regulatory actions on human 

health and the environment. FIFRA SAP 

is a Federal advisory committee 

established in 1975 under FIFRA that 

operates in accordance with 

requirements of the Federal Advisory 

Committee Act (5 U.S.C. Appendix). 

The FIFRA SAP is composed of a 

permanent panel consisting of seven 

members who are appointed by the EPA 

Administrator from nominees provided 

by the National Institutes of Health 

(NIH) and the National Science 

Foundation (NSF). FIFRA established a 

Science Review Board (SRB) consisting 

of at least 60 scientists who are available 

to FIFRA SAP on an ad hoc basis to 

assist in reviews conducted by FIFRA 

SAP. As a scientific peer review 

mechanism, FIFRA SAP provides 

comments, evaluations, and 

recommendations to improve the 

effectiveness and quality of analyses 

made by Agency scientists. Members of 

FIFRA SAP are scientists who have 

sufficient professional qualifications, 

including training and experience, to 

provide expert advice and 

recommendation to the Agency. 

B. Public Meeting 

EPA conducts human health risk 

assessments to evaluate the potential 

health effects of pesticides and toxic 

chemicals in residential and 

occupational settings based on the use 

pattern or conditions of use. For 

evaluating effects via the inhalation 

route, registrants and manufacturers 

conduct subchronic inhalation toxicity 

studies according to test guideline 

requirements (OPPTS 870.3465, 40 CFR 

part 798, OECD TG 412 and 413). In 

these studies, several groups of 

experimental animals are exposed daily 

for a defined period to graduated 

concentrations of test substance as a gas 

or aerosol/particulate. These studies are 

used to determine a no observed adverse 

effect concentration (NOAEC) for effects 

following repeated inhalation exposure 

that may be used for human health risk 

assessment. 

The anatomy and physiology of 

human and animal respiratory tracts 

differ in several ways that can impact 

changes in airflow and deposition of 

inhaled substances and, therefore, 

influence the animal to human dose 

response extrapolation. Furthermore, 

traditional in vivo toxicity tests used to 

extrapolate from test species to humans 

are expensive, time-consuming, and can 

cause stress to laboratory animals. As a 

result, efforts to develop alternative 

methods and strategies for evaluating 

toxic effects from inhaled chemicals 

using in vitro test systems with human 

tissues combined with human 

dosimetry modeling provide inherent 

advantages over using in vivo animal 

studies. These alternatives are also 

consistent with the National Research 

Council’s (NRC) long-range vision to 

advance toxicity testing in the 21st 

century, as well as the strategic roadmap 

released by Interagency Coordinating 

Committee on the Validation of 

Alternative Methods (ICCVAM) to 

accomplish NRC’s vision in the United 

States. 

New approach methodologies (NAMs) 

has been adopted as a broadly 

descriptive reference to any non-animal 

technology, methodology, approach, or 

combination thereof that can be used to 

provide information on chemical hazard 

and risk assessment. An example of a 

NAM for refining inhalation risk 

assessment has been submitted to the 

Agency for the pesticide chlorothalonil. 

Chlorothalonil is a contact irritant that 

has been found to be toxic via the 

inhalation route. Due to the irritant 

nature of chlorothalonil and animal 

welfare concerns, the registrant 

(Syngenta Crop Protection) indicated 

that a 90-day inhalation toxicity study 

was not feasible to fulfill the regulatory 

requirement of a subchronic inhalation 

study. Subsequently, Syngenta proposed 

an alternative approach using an in vitro 

assay (MucilAirTM using human nasal 

tissue) to characterize the hazard of 

chlorothalonil and derive a point of 

departure (POD) for use in human 

health risk assessment. In order to 

calculate human equivalent 

concentrations for the purposes of 

human health risk assessment, an in 


sradovich on DSK3GMQ082PROD with NOTICES
39090 Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices 

vitro POD has been proposed in 

conjunction with surface concentrations 

of deposited chlorothalonil particles 

from a computational fluid dynamic 

(CFD) model for the upper airway of a 

human. As a proof of concept, Syngenta 

also used the calculated human 

equivalent concentrations for pesticide 

operators/applicators to provide 

potential risk estimates supported by 

this proposed approach. 

The Agency is soliciting advice from 

the FIFRA Scientific Advisory Panel 

(SAP) on the derivation of the POD from 

the in vitro assay and the integration of 

the in vitro POD for calculation of 

human equivalent concentrations for the 

inhalation risk assessment. 

Chlorothalonil will be presented as a 

case study to solicit advice on the 

proposed overall approach expected to 

be applied to other pesticides or 

industrial chemicals in the future. 

The 4-day, in-person FIFRA SAP 

meeting may also be webcast. You may 

refer to the FIFRA SAP website at http:// 

www.epa.gov/sap for information on 

how to access the webcast. Please note 

that the webcast for the in-person 

meeting is a supplementary public 

process provided only for convenience. 

If difficulties arise resulting in 

webcasting outages, the in-person 

meeting will continue as planned. 

C. Virtual Preparatory Meeting 

Preceding the in-person meeting, 

there will be a half-day virtual 

preparatory meeting, conducted via 

webinar using Adobe Connect, to 

consider and review the clarity and 

scope of the meeting’s draft charge 

questions. The virtual preparatory 

meeting will be webcast only, and 

registration is required to attend this 

virtual meeting. The date and 

registration instructions will be 

announced in a future Federal Register 

Notice and on the FIFRA SAP website 

(http://www.epa.gov/sap) by midSeptember. 

D. FIFRA SAP Documents and Meeting 

Minutes 

EPA’s background paper, charge/ 

questions to FIFRA SAP, and related 

supporting materials will be available 

by early September 2018. In addition, a 

list of candidates under consideration as 

prospective ad hoc panelists for this 

meeting will be available for a 15-day 

public comment period by early to midSeptember 2018. You may obtain 

electronic copies of most meeting 

documents, including FIFRA SAP 

composition (i.e., members and ad hoc 

members for this meeting) and the 

meeting agenda, at http://

www.regulations.gov and the FIFRA 

SAP website at http://www.epa.gov/ 

scipoly/sap. 

FIFRA SAP will prepare the meeting 

minutes and final report approximately 

90 calendar days after the in-person 

meeting. The meeting minutes and final 

report will be posted on the FIFRA SAP 

website: https://www.epa.gov/sap and 

may be accessed in the docket at https:// 

www.regulations.gov. 

Authority: 7 U.S.C. 136 et. seq.; 21 U.S.C. 

301 et seq. 

Dated: July 12, 2018. 

Stanley Barone, Jr., 

Acting Director, Office of Science 

Coordination and Policy. 

[FR Doc. 2018–16990 Filed 8–7–18; 8:45 am] 

BILLING CODE 6560–50–P 

FEDERAL COMMUNICATIONS 

COMMISSION 

Information Collection Approved by 

the Office of the Management and 

Budget (OMB) 

AGENCY: Federal Communications 

Commission. 

ACTION: Notice. 

SUMMARY: The Federal Communications 

Commission has received Office of 

Management and Budget (OMB) 

approval for a revised information 

collection pursuant to the Paperwork 

Reduction Act (PRA) of 1995. An agency 

may not conduct or sponsor a collection 

of information unless it displays a 

currently valid OMB control number, 

and no person is required to respond to 

a collection of information unless it 

displays a currently valid OMB control 

number. Comments concerning the 

accuracy of the burden estimates and 

any suggestions for reducing the burden 

should be directed to the person listed 

in the FOR FURTHER INFORMATION

CONTACT section below. 

FOR FURTHER INFORMATION CONTACT: 

Nicole Ongele, Office of the Managing 

Director, at (202) 418–2991, or via 

email: Nicole.Ongele@fcc.gov. 

SUPPLEMENTARY INFORMATION: 

OMB Control Number: 3060–0986. 

OMB Approval Date: July 2, 2018. 

OMB Expiration Date: July 31, 2021. 

Title: High-Cost Universal Service 

Support. 

Form Numbers: FCC Form 481 and 

FCC Form 525. 

Respondents: Business or other forprofit, not-for-profit institutions and 

state, local or tribal government. 

Number of Respondents and 

Responses: 1,877 respondents; 14,335 

responses. 

Estimated Time per Response: 0.5–15 

hours. 

Frequency of Response: On occasion, 

quarterly and annual reporting 

requirements, recordkeeping 

requirement and third party disclosure 

requirement. 

Obligation to Respond: Required to 

obtain or retain benefits. Statutory 

authority for this information collection 

is contained in 47 U.S.C. 151–154, 155, 

201–206, 214, 218–220, 251, 252, 254, 

256, 303(r), 332, 403, 405, 410, and 

1302. 

Total Annual Burden: 63,486 hours. 

Total Annual Cost: No cost. 

Privacy Act Impact Assessment: No 

impact(s). 

Nature and Extent of Confidentiality: 

The Commission notes that USAC must 

preserve the confidentiality of all data 

obtained from respondents; must not 

use the data except for purposes of 

administering the universal service 

programs; and must not disclose data in 

company-specific form unless directed 

to do so by the Commission. Privatelyheld rate-of-return carriers may file the 

financial information they disclose in 

FCC Form 481 pursuant to a protective 

order. 

Needs and Uses: The Commission 

received OMB approval for this revised 

information collection. On July 7, 2017, 

the Commission released Connect 

America Fund; ETC Annual Reports and 

Certifications, WC Docket Nos. 10–90 

and 14–58, Order, FCC 17–87 (ETC 

Reporting Streamlining Order), which 

streamlined the annual reporting 

requirements for eligible 

telecommunications carriers (ETCs) that 

receive high-cost universal service 

support by eliminating several rules that 

are either duplicative of other reporting 

requirements or are simply no longer 

necessary. In doing this, the 

Commission reduced ETCs’ regulatory 

burdens while strengthening the tools 

for program oversight in furtherance of 

our goal of protecting the high cost 

universal support program against 

waste, fraud, and abuse. Specifically, 

the Commission eliminated its annual 

high-cost reporting rules regarding 

network outage information, unfulfilled 

service requests, the number of 

complaints received by an ETC per 

1,000 subscribers for both voice and 

broadband services, pricing for voice 

and broadband services, service quality 

certification, and duplicate filing of the 

FCC Form 481 without compromising 

its ability to monitor whether ETCs are 

using high-cost universal service 

support for its intended purpose, 

adopted in the ETC Reporting 

Streamlining Order. 

This revised information collection 

addresses the removal of those 

duplicative or otherwise unnecessary 


sradovich on DSK3GMQ082PROD with NOTICES